These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 27475647)
1. Quantification of Circulating Free DNA as a Diagnostic Marker in Gall Bladder Cancer. Kumari S; Tewari S; Husain N; Agarwal A; Pandey A; Singhal A; Lohani M Pathol Oncol Res; 2017 Jan; 23(1):91-97. PubMed ID: 27475647 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic Value of Circulating Free DNA Integrity and Global Methylation Status in Gall Bladder Carcinoma. Kumari S; Husain N; Agarwal A; Neyaz A; Gupta S; Chaturvedi A; Lohani M; Sonkar AA Pathol Oncol Res; 2019 Jul; 25(3):925-936. PubMed ID: 29376201 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of quantification of circulating free DNA for gall bladder cancer using a chemiluminescence DNA biosensor system based on DNA G-quadruplex/ hemin enzyme. Ying H; Fengying S; Feng H; Yanhong W; Xianru X; Xiaolei T Transl Oncol; 2021 Jan; 14(1):100928. PubMed ID: 33212417 [TBL] [Abstract][Full Text] [Related]
4. Comparison of circulating DNA in malignant neoplasia from diverse locations: Investigating a diagnostic role. Kumari S; Mishra S; Husain N; Verma T; Tiwari V; Kaif M; Agarwal A; Rastogi M; Shukla S; Sonkar AA Indian J Pathol Microbiol; 2022; 65(1):93-99. PubMed ID: 35074971 [TBL] [Abstract][Full Text] [Related]
5. Fragile histidine triad (FHIT) gene and its association with p53 protein expression in the progression of gall bladder cancer. Priya TP; Kapoor VK; Krishnani N; Agrawal V; Agarwal S Cancer Invest; 2009 Aug; 27(7):764-73. PubMed ID: 19452299 [TBL] [Abstract][Full Text] [Related]
6. The diagnostic role of circulating inflammation-based biomarker in gallbladder carcinoma. Liu XF; Zhou LY; Wei ZH; Liu JX; Li A; Wang XZ; Ying HQ Biomark Med; 2018 Oct; 12(10):1095-1103. PubMed ID: 30191731 [TBL] [Abstract][Full Text] [Related]
7. Anticipatory extended cholecystectomy: the 'Lucknow' approach for thick walled gall bladder with low suspicion of cancer. Kapoor VK; Singh R; Behari A; Sharma S; Kumar A; Prakash A; Singh RK; Kumar A; Saxena R Chin Clin Oncol; 2016 Feb; 5(1):8. PubMed ID: 26932432 [TBL] [Abstract][Full Text] [Related]
8. Circulating cell-free DNA: a promising marker of regional lymphonode metastasis in breast cancer patients. Agostini M; Enzo MV; Bedin C; Belardinelli V; Goldin E; Del Bianco P; Maschietto E; D'Angelo E; Izzi L; Saccani A; Zavagno G; Nitti D Cancer Biomark; 2012; 11(2-3):89-98. PubMed ID: 23011155 [TBL] [Abstract][Full Text] [Related]
9. Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis. Leng S; Zheng J; Jin Y; Zhang H; Zhu Y; Wu J; Xu Y; Zhang P Clin Chim Acta; 2018 Feb; 477():160-165. PubMed ID: 29113814 [TBL] [Abstract][Full Text] [Related]
10. Xanthogranulomatous cholecystitis: a clinicopathological study of its association with gallbladder carcinoma. Zhuang PY; Zhu MJ; Wang JD; Zhou XP; Quan ZW; Shen J J Dig Dis; 2013 Jan; 14(1):45-50. PubMed ID: 23134201 [TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs in gallbladder cancer: Is serum assay of diagnostic value? Srivastava P; Mishra S; Agarwal A; Pandey A; Husain N Pathol Res Pract; 2023 Feb; 242():154320. PubMed ID: 36682281 [TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of human telomerase reverse transcriptase (hTERT) expression in patients with gall bladder disease and carcinoma. Deblakshmi RK; Deka M; Saikia AK; Sharma BK; Singh N; Das NN; Bose S Asian Pac J Cancer Prev; 2015; 16(7):2923-8. PubMed ID: 25854384 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients. Bedin C; Enzo MV; Del Bianco P; Pucciarelli S; Nitti D; Agostini M Int J Cancer; 2017 Apr; 140(8):1888-1898. PubMed ID: 27943272 [TBL] [Abstract][Full Text] [Related]
14. Quantification of free circulating DNA as a diagnostic marker in lung cancer. Sozzi G; Conte D; Leon M; Ciricione R; Roz L; Ratcliffe C; Roz E; Cirenei N; Bellomi M; Pelosi G; Pierotti MA; Pastorino U J Clin Oncol; 2003 Nov; 21(21):3902-8. PubMed ID: 14507943 [TBL] [Abstract][Full Text] [Related]
15. Aberrant Telomere Length in Circulating Cell-Free DNA as Possible Blood Biomarker with High Diagnostic Performance in Endometrial Cancer. Benati M; Montagnana M; Danese E; Mazzon M; Paviati E; Garzon S; Laganà AS; Casarin J; Giudici S; Raffaelli R; Ghezzi F; Franchi M; Lippi G Pathol Oncol Res; 2020 Oct; 26(4):2281-2289. PubMed ID: 32462419 [TBL] [Abstract][Full Text] [Related]
17. Serum vascular endothelial growth factors C and D as forecast tools for patients with gallbladder carcinoma. Liu MC; Jiang L; Hong HJ; Meng ZW; Du Q; Zhou LY; She FF; Chen YL Tumour Biol; 2015 Aug; 36(8):6305-12. PubMed ID: 25801241 [TBL] [Abstract][Full Text] [Related]
18. Use of a new generation of capillary electrophoresis to quantify circulating free DNA in non-small cell lung cancer. Chiappetta C; Anile M; Leopizzi M; Venuta F; Della Rocca C Clin Chim Acta; 2013 Oct; 425():93-6. PubMed ID: 23892142 [TBL] [Abstract][Full Text] [Related]
19. Roles of Salmonella typhi and Salmonella paratyphi in Gallbladder Cancer Development. Shukla R; Shukla P; Behari A; Khetan D; Chaudhary RK; Tsuchiya Y; Ikoma T; Asai T; Nakamura K; Kapoor VK Asian Pac J Cancer Prev; 2021 Feb; 22(2):509-516. PubMed ID: 33639667 [TBL] [Abstract][Full Text] [Related]
20. Aberrant reduction of telomere repetitive sequences in plasma cell-free DNA for early breast cancer detection. Wu X; Tanaka H Oncotarget; 2015 Oct; 6(30):29795-807. PubMed ID: 26356673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]